2021
DOI: 10.1002/dta.2988
|View full text |Cite
|
Sign up to set email alerts
|

Label‐free proteomics for discovering biomarker candidates of RAD140 administration to castrated horses

Abstract: Selective androgen receptor (AR) modulators (SARMs) are potent anabolic agents with a high potential of misuse in horseracing and equestrian sports. In this study, we applied label-free proteomics to discover plasma protein biomarkers in geldings (castrated horses) after administration with a popular SARM named RAD140. Tryptic peptides were prepared from plasma samples and analyzed by nano-flow ultrahighperformance liquid chromatography-high-resolution tandem mass spectrometry (nano-UHPLC-HRMS/MS) using data-i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 39 publications
0
4
0
Order By: Relevance
“…Some suggest the use of metabolomics as an answer, but there are many limitations still to be addressed before this could become an efficient option [ 30 ]. Another possible option would be to test for biomarkers of drug doping, alleviating the need for the time-consuming process of testing for each illicit substance [ [31] , [32] , [33] ]. This would first require identification of such biomarkers.…”
Section: Introductionmentioning
confidence: 99%
“…Some suggest the use of metabolomics as an answer, but there are many limitations still to be addressed before this could become an efficient option [ 30 ]. Another possible option would be to test for biomarkers of drug doping, alleviating the need for the time-consuming process of testing for each illicit substance [ [31] , [32] , [33] ]. This would first require identification of such biomarkers.…”
Section: Introductionmentioning
confidence: 99%
“…To continuously improve their detection capabilities and widen their detection time frames toward major doping agents such as synthetic androgenic anabolic steroids (AAS), doping control laboratories constantly seek analytical enhancements consistent with the processing of several thousand samples per year. These factors limited the application of highly sensitive low-flow based strategies to a few peptide-based targeted applications requiring advanced sensitivity, such as the targeted detection of erythropoietin, , relaxin, peptide toxins, peptide drugs, or proteomics biomarker discovery induced by doping practices , and unknown protein characterization . To a lower extent, low-flow drug screening methods are reported but are hardly compatible with the processing of tens of thousands samples per year .…”
Section: Introductionmentioning
confidence: 99%
“…Some suggest the use of metabolomics as an answer, but there are many limitations still to be addressed before this could become an e cient option [30]. Another possible option would be to test for biomarkers of drug doping, alleviating the need for the time-consuming process of testing for each illicit substance [31][32][33]. This would rst require identi cation of such biomarkers.…”
Section: Introductionmentioning
confidence: 99%